Capturing the primordial Kras mutation initiating urethane carcinogenesis.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
14 04 2020
14 04 2020
Historique:
received:
06
09
2019
accepted:
23
03
2020
entrez:
15
4
2020
pubmed:
15
4
2020
medline:
22
7
2020
Statut:
epublish
Résumé
The environmental carcinogen urethane exhibits a profound specificity for pulmonary tumors driven by an oncogenic Q
Identifiants
pubmed: 32286309
doi: 10.1038/s41467-020-15660-8
pii: 10.1038/s41467-020-15660-8
pmc: PMC7156420
doi:
Substances chimiques
Protein Isoforms
0
Urethane
3IN71E75Z5
Hras protein, mouse
EC 3.6.5.2
Proto-Oncogene Proteins p21(ras)
EC 3.6.5.2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1800Subventions
Organisme : NCI NIH HHS
ID : P01 CA203657
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014236
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA094184
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM127062
Pays : United States
Références
You, M., Candrian, U., Maronpot, R. R., Stoner, G. D. & Anderson, M. W. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl Acad. Sci. USA 86, 3070–3074 (1989).
pubmed: 2654935
doi: 10.1073/pnas.86.9.3070
Forkert, P. G. Mechanisms of lung tumorigenesis by ethyl carbamate and vinyl carbamate. Drug Metab. Rev. 42, 355–378 (2010).
pubmed: 20205516
doi: 10.3109/03602531003611915
Westcott, P. M. et al. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature 517, 489–492 (2015).
pubmed: 25363767
doi: 10.1038/nature13898
Nuzum, E. O., Malkinson, A. M. & Beer, D. G. Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas. Mol. Carcinog. 3, 287–295 (1990).
pubmed: 2244961
doi: 10.1002/mc.2940030509
Dwyer-Nield, L. D. et al. Epistatic interactions govern chemically-induced lung tumor susceptibility and Kras mutation site in murine C57BL/6J-ChrA/J chromosome substitution strains. Int. J. Cancer 126, 125–132 (2010).
pubmed: 19609923
pmcid: 2783521
doi: 10.1002/ijc.24743
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J. & Der, C. J. Drugging the undruggable RAS: mission possible? Nat. Rev. Drug Disco. 13, 828–851 (2014).
doi: 10.1038/nrd4389
Prior, I. A., Lewis, P. D. & Mattos, C. A comprehensive survey of Ras mutations in cancer. Cancer Res. 72, 2457–2467 (2012).
pubmed: 22589270
pmcid: 3354961
doi: 10.1158/0008-5472.CAN-11-2612
Hernandez, L. G. & Forkert, P. G. In vivo mutagenicity of vinyl carbamate and ethyl carbamate in lung and small intestine of F1 (Big Blue x A/J) transgenic mice. Int. J. Cancer 120, 1426–1433 (2007).
pubmed: 17205523
doi: 10.1002/ijc.22502
Fox, E. J., Reid-Bayliss, K. S., Emond, M. J. & Loeb, L. A. Accuracy of next generation sequencing platforms. Gener. Seq. Appl. 1, 1000106 (2014).
Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W. & Vogelstein, B. Detection and quantification of rare mutations with massively parallel sequencing. Proc. Natl Acad. Sci. USA 108, 9530–9535 (2011).
pubmed: 21586637
doi: 10.1073/pnas.1105422108
Schmitt, M. W. et al. Detection of ultra-rare mutations by next-generation sequencing. Proc. Natl Acad. Sci. USA 109, 14508–14513 (2012).
pubmed: 22853953
doi: 10.1073/pnas.1208715109
Lou, D. I. et al. High-throughput DNA sequencing errors are reduced by orders of magnitude using circle sequencing. Proc. Natl Acad. Sci. USA 110, 19872–19877 (2013).
pubmed: 24243955
doi: 10.1073/pnas.1319590110
Jee, J. et al. Rates and mechanisms of bacterial mutagenesis from maximum-depth sequencing. Nature 534, 693–696 (2016).
pubmed: 27338792
pmcid: 4940094
doi: 10.1038/nature18313
Blattner, F. R. et al. The complete genome sequence of Escherichia coli K-12. Science 277, 1453–1462 (1997).
pubmed: 9278503
doi: 10.1126/science.277.5331.1453
Waterston, R. H. et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520–562 (2002).
pubmed: 12466850
doi: 10.1038/nature01262
Hindson, B. J. et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem. 83, 8604–8610 (2011).
pubmed: 22035192
pmcid: 3216358
doi: 10.1021/ac202028g
Fernando, R. C., Nair, J., Barbin, A., Miller, J. A. & Bartsch, H. Detection of 1,N
pubmed: 8761431
doi: 10.1093/carcin/17.8.1711
Forkert, P. G. et al. Oxidation of vinyl carbamate and formation of 1,N
pubmed: 17296623
doi: 10.1124/dmd.106.013805
Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941–D947 (2019).
pubmed: 30371878
doi: 10.1093/nar/gky1015
Winters, I. P. et al. Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity. Nat. Commun. 8, 2053 (2017).
pubmed: 29233960
pmcid: 5727199
doi: 10.1038/s41467-017-01519-y
Borrego, A. et al. Germline control of somatic Kras mutations in mouse lung tumors. Mol. Carcinog. 57, 745–751 (2018).
pubmed: 29500885
doi: 10.1002/mc.22796
Burd, C. E. et al. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. Cancer Disco. 4, 1418–1429 (2014).
doi: 10.1158/2159-8290.CD-14-0729
Kiessling, M. K. et al. Mutant HRAS as novel target for MEK and mTOR inhibitors. Oncotarget 6, 42183–42196 (2015).
pubmed: 26544513
pmcid: 4747218
doi: 10.18632/oncotarget.5619
Li, S., Balmain, A. & Counter, C. M. A model for RAS mutation patterns in cancers: finding the sweet spot. Nat. Rev. Cancer 18, 767–777 (2018).
pubmed: 30420765
doi: 10.1038/s41568-018-0076-6
Dragani, T. A., Manenti, G. & Della Porta, G. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res. 51, 6299–6303 (1991).
pubmed: 1933890
Heston, W. E., Vlahakis, G. & Deringer, M. K. High incidence of spontaneous hepatomas and the increase of this incidence with urethan in C3H, C3Hf, and C3He male mice. J. Natl Cancer Inst. 24, 425–435 (1960).
pubmed: 14401531
doi: 10.1093/jnci/24.3.721
Guerra, C. et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11, 291–302 (2007).
pubmed: 17349585
doi: 10.1016/j.ccr.2007.01.012
Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437–450 (2003).
pubmed: 14706336
doi: 10.1016/S1535-6108(03)00309-X
Grebe, S. K. & Singh, R. J. LC-MS/MS in the clinical laboratory—Where to from here? Clin. Biochem Rev. 32, 5–31 (2011).
pubmed: 21451775
pmcid: 3052391
Guengerich, F. P. & Kim, D. H. Enzymatic oxidation of ethyl carbamate to vinyl carbamate and its role as an intermediate in the formation of 1,N
pubmed: 1912327
doi: 10.1021/tx00022a003
Nomeir, A. A., Ioannou, Y. M., Sanders, J. M. & Matthews, H. B. Comparative metabolism and disposition of ethyl carbamate (urethane) in male Fischer 344 rats and male B6C3F1 mice. Toxicol. Appl. Pharm. 97, 203–215 (1989).
doi: 10.1016/0041-008X(89)90326-8
Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
pubmed: 3776390
pmcid: 3776390
doi: 10.1038/nature12477
Kucab, J. E. et al. A compendium of mutational signatures of environmental agents. Cell 177, 821–836 (2019).
pubmed: 6506336
pmcid: 6506336
doi: 10.1016/j.cell.2019.03.001
Haradhvala, N. J. et al. Mutational strand asymmetries in cancer genomes reveal mechanisms of DNA damage and repair. Cell 164, 538–549 (2016).
pubmed: 26806129
pmcid: 4753048
doi: 10.1016/j.cell.2015.12.050
Newlaczyl, A. U., Coulson, J. M. & Prior, I. A. Quantification of spatiotemporal patterns of Ras isoform expression during development. Sci. Rep. 7, 41297 (2017).
pubmed: 28117393
pmcid: 5259795
doi: 10.1038/srep41297
Li, B. et al. A comprehensive mouse transcriptomic bodymap across 17 tissues by RNA-seq. Sci. Rep. 7, 4200 (2017).
pubmed: 28646208
pmcid: 5482823
doi: 10.1038/s41598-017-04520-z
Shen, Y. et al. A map of the cis-regulatory sequences in the mouse genome. Nature 488, 116–120 (2012).
pubmed: 4041622
pmcid: 4041622
doi: 10.1038/nature11243
Phallen, J. et al. Direct detection of early-stage cancers using circulating tumor DNA. Sci. Transl. Med. 9, eaan2415 (2017).
pubmed: 28814544
pmcid: 6714979
doi: 10.1126/scitranslmed.aan2415
Ichikawa, T. et al. The activation of K-ras gene at an early stage of lung tumorigenesis in mice. Cancer Lett. 107, 165–170 (1996).
pubmed: 8947508
doi: 10.1016/0304-3835(96)04351-0
Yano, T., Yuasa, M., Murakami, A., Ichikawa, T. & Hagiwara, K. The detection of chemically initiated cells having the mutation of K-ras gene at an early stage of lung carcinogenesis in mice. Anal. Biochem. 244, 187–189 (1997).
pubmed: 9025932
doi: 10.1006/abio.1996.9902
Spella, M. et al. Club cells form lung adenocarcinomas and maintain the alveoli of adult mice. Elife 8, e45571 (2019).
pubmed: 31140976
pmcid: 6606035
doi: 10.7554/eLife.45571
van Mansfeld, A. D. & Bos, J. L. PCR-based approaches for detection of mutated ras genes. PCR Methods Appl. 1, 211–216 (1992).
pubmed: 1362126
doi: 10.1101/gr.1.4.211
Pender, A. et al. Efficient genotyping of KRAS mutant non-small cell lung cancer using a multiplexed droplet digital PCR approach. PLoS ONE 10, e0139074 (2015).
pubmed: 26413866
pmcid: 4586384
doi: 10.1371/journal.pone.0139074
Krauthammer, M. et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat. Genet. 44, 1006–1014 (2012).
pubmed: 22842228
pmcid: 3432702
doi: 10.1038/ng.2359
Pershing, N. L. et al. Rare codons capacitate Kras-driven de novo tumorigenesis. J. Clin. Invest. 125, 222–233 (2015).
pubmed: 25437878
doi: 10.1172/JCI77627
Huang, L., Carney, J., Cardona, D. M. & Counter, C. M. Decreased tumorigenesis in mice with a Kras point mutation at C118. Nat. Commun. 5, 5410 (2014).
pubmed: 25394415
pmcid: 4234187
doi: 10.1038/ncomms6410
Temko, D., Tomlinson, I. P. M., Severini, S., Schuster-Bockler, B. & Graham, T. A. The effects of mutational processes and selection on driver mutations across cancer types. Nat. Commun. 9, 1857 (2018).
pubmed: 29748584
pmcid: 5945620
doi: 10.1038/s41467-018-04208-6
Buisson, R. et al. Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features. Science 364, eaaw2872 (2019).
pubmed: 31249028
pmcid: 6731024
doi: 10.1126/science.aaw2872
Dietlein, F. et al. Identification of cancer driver genes based on nucleotide context. Nat. Genet. 52, 208–218 (2020).
pubmed: 32015527
doi: 10.1038/s41588-019-0572-y
Hancock, J. F. Ras proteins: different signals from different locations. Nat. Rev. Mol. Cell Biol. 4, 373–384 (2003).
pubmed: 12728271
doi: 10.1038/nrm1105
Kovalski, J. R. et al. The functional proximal proteome of oncogenic Ras includes mTORC2. Mol. Cell 73, 830–44 e12 (2019).
pubmed: 30639242
pmcid: 6386588
doi: 10.1016/j.molcel.2018.12.001
Adhikari, H. & Counter, C. M. Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability. Nat. Commun. 9, 3646 (2018).
pubmed: 30194290
pmcid: 6128905
doi: 10.1038/s41467-018-05692-6
Villalonga, P. et al. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling. Mol. Cell Biol. 21, 7345–7354 (2001).
pubmed: 11585916
pmcid: 99908
doi: 10.1128/MCB.21.21.7345-7354.2001
Elad-Sfadia, G., Haklai, R., Balan, E. & Kloog, Y. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. J. Biol. Chem. 279, 34922–34930 (2004).
pubmed: 15205467
doi: 10.1074/jbc.M312697200
To, M. D. et al. Kras regulatory elements and exon 4A determine mutation specificity in lung cancer. Nat. Genet. 40, 1240–1244 (2008).
pubmed: 18758463
pmcid: 2654781
doi: 10.1038/ng.211
McCreery, M. Q. & Balmain, A. Chemical carcinogenesis models of cancer: back to the future. Annu Rev. Cancer Biol. 1, 295–312 (2017).
doi: 10.1146/annurev-cancerbio-050216-122002
Simanshu, D. K., Nissley, D. V. & McCormick, F. RAS proteins and their regulators in human disease. Cell 170, 17–33 (2017).
pubmed: 28666118
pmcid: 5555610
doi: 10.1016/j.cell.2017.06.009
Stephen, A. G., Esposito, D., Bagni, R. K. & McCormick, F. Dragging ras back in the ring. Cancer Cell 25, 272–281 (2014).
pubmed: 24651010
doi: 10.1016/j.ccr.2014.02.017
Adar, S., Hu, J., Lieb, J. D. & Sancar, A. Genome-wide kinetics of DNA excision repair in relation to chromatin state and mutagenesis. Proc. Natl Acad. Sci. USA 113, E2124–E2133 (2016).
pubmed: 27036006
doi: 10.1073/pnas.1603388113
Hoffler, U. & Ghanayem, B. I. Increased bioaccumulation of urethane in CYP2E1−/− versus CYP2E1+/+ mice. Drug Metab. Dispos. 33, 1144–1150 (2005).
pubmed: 15879495
doi: 10.1124/dmd.105.003806
Supek, F. & Lehner, B. Clustered mutation signatures reveal that error-prone DNA repair targets mutations to active genes. Cell 170, 534–547 (2017).
pubmed: 28753428
doi: 10.1016/j.cell.2017.07.003
To, M. D. et al. A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nat. Genet. 38, 926–930 (2006).
pubmed: 16823377
pmcid: 4461000
doi: 10.1038/ng1836
Dassano, A. et al. Mouse pulmonary adenoma susceptibility 1 locus is an expression QTL modulating Kras-4A. PLoS Genet. 10, e1004307 (2014).
pubmed: 24743582
pmcid: 3990522
doi: 10.1371/journal.pgen.1004307
Hanawalt, P. C. & Spivak, G. Transcription-coupled DNA repair: two decades of progress and surprises. Nat. Rev. Mol. Cell Biol. 9, 958–970 (2008).
pubmed: 19023283
doi: 10.1038/nrm2549
Zheng, C. L. et al. Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes. Cell Rep. 9, 1228–1234 (2014).
pubmed: 25456125
pmcid: 4254608
doi: 10.1016/j.celrep.2014.10.031
Pylayeva-Gupta, Y., Grabocka, E. & Bar-Sagi, D. RAS oncogenes: weaving a tumorigenic web. Nat. Rev. Cancer 11, 761–774 (2011).
pubmed: 21993244
pmcid: 3632399
doi: 10.1038/nrc3106
Haigis, K. M. KRAS alleles: the devil is in the detail. Trends Cancer 3, 686–697 (2017).
pubmed: 28958387
pmcid: 5824632
doi: 10.1016/j.trecan.2017.08.006
Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res. 49, 4682–4689 (1989).
pubmed: 2547513
Xu, X. et al. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma. Proc. Natl Acad. Sci. USA 109, 4910–4915 (2012).
pubmed: 22411819
doi: 10.1073/pnas.1112499109
Morgenstern, J. P. & Land, H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587–3596 (1990).
pubmed: 2194165
pmcid: 331014
doi: 10.1093/nar/18.12.3587
O’Hayer, K. M. & Counter, C. M. A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro. Methods Enzymol. 407, 637–647 (2006).
pubmed: 16757358
doi: 10.1016/S0076-6879(05)07050-3
Norrander, J., Kempe, T. & Messing, J. Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis. Gene 26, 101–106 (1983).
pubmed: 6323249
doi: 10.1016/0378-1119(83)90040-9
Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 46, W537–W544 (2018).
pubmed: 29790989
pmcid: 6030816
doi: 10.1093/nar/gky379
Zhang, J., Kobert, K., Flouri, T. & Stamatakis, A. PEAR: a fast and accurate Illumina Paired-End reAd mergeR. Bioinformatics 30, 614–620 (2014).
pubmed: 24142950
doi: 10.1093/bioinformatics/btt593
Arbeithuber, B., Makova, K. D. & Tiemann-Boege, I. Artifactual mutations resulting from DNA lesions limit detection levels in ultrasensitive sequencing applications. DNA Res. 23, 547–559 (2016).
pubmed: 27477585
pmcid: 5144678
doi: 10.1093/dnares/dsw038
Rowlands, V. et al. Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA. Sci. Rep. 9, 12620 (2019).
pubmed: 31477768
pmcid: 6718424
doi: 10.1038/s41598-019-49043-x
Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408 (2001).
doi: 10.1006/meth.2001.1262